CSF levels of cytokines in neuro-Behçet's disease

Clinical Neurology and Neurosurgery

Volumn 111, Issue 6, 2009, Pages 507-510

  Borhani Haghighi, A ^a   Ittehadi, H ^a   Nikseresht, A R ^a   Rahmati, J ^b   Ghaffari Poorjahromi, S ^a   Pourabbas, B ^a   Nazarinia, M A ^a   Habibagahi, Z ^a   Fattahi, M J ^c   Ghaderi, A ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beh et's disease; Cerebrospinal fluid; Chemokines; Cytokines; Neuro Beh et's disease

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; IMMUNOPATHOGENESIS; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; VIRUS MENINGITIS;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; FEMALE; HEADACHE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MENINGITIS, VIRAL; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 67349172930     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.02.001     Document Type: Article

References (23)

1. Borhani Haghighi A., Pourmand R., and Nikseresht A.R. Neuro-Behçet's disease: a review. The Neurologist 11 (2005) 80-89
2. Zouboulis C.C., and May T. Pathogenesis of adamantiades-Behçet's disease. Med Microbiol Immunol 192 (2003) 149-155
3. Akman-Demir G., Serdaroglu P., Tasci B., and the Neuro-Behcet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 122 (1999) 2171-2182
4. Kidd D., Steuer A., Denman A.M., and Rudge P. Neurological complications in Behçet's syndrome. Brain 122 (1999) 2183-2194
5. Akpolat T., Koc Y., Yeniay I., Akpek G., Güllü I., Kansu E., et al. Familial Behçet's disease. Eur J Med 1 November (7) (1992) 391-395
6. Turan B., Gallati H., Erdi H., Gürler A., Michel B.A., and Villiger P.M. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24 January (1) (1997) 128-132
7. Katsantonis J., Adler Y., Orfanos C.E., and Zouboulis C.C. Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201 1 (2000) 37-39
8. Hamzaoui K., Hamzaoui A., Ghorbel I., Khanfir M., and Houman H. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease. Scand J Immunol 64 December (6) (2006) 655-660
9. Niino M., Ogata A., Kikuchi S., Tashiro K., and Nishihira J. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease. J Neurol Sci 179 October (Suppl. 1-2) (2000) 127-131
10. Wang C.R., Chuang C.Y., and Chen C.Y. Anticardiolipin antibodies and interleukin-6 in cerebrospinal fluid and blood of Chinese patients with neuro-Behçet's syndrome. Clin Exp Rheumatol 10 (1992) 599-602
11. Hirohata S., Isshi K., Oguchi H., Ohse T., Haraoka H., Takeuchi A., et al. Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet's syndrome. Clin Immunol Immunopathol 82 January (1) (1997) 12-17
12. Hirohata S., Suda H., and Hashimoto T. Low dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci 159 (1998) 181-185
13. Hatachi S., Nakazawa T., Morinobu A., Kasagi S., Kogata Y., Kageyama G., et al. A pediatric patient with neuro-Behçet's disease. Mod Rheumatol 16 5 (2006) 321-323
14. Nakano Y., Hatanaka Y., Ikebuchi E., Shimizu T., Nanko S., and Utsumii T. A case of Neuro-Behçet's disease with early onset of bipolar mood disorder. Seishin Shinkeigaku Zasshi 106 5 (2004) 564-573
15. Saruhan-Direskeneli G., Yentur S.P., Akman-Demir G., Isik N., and Serdaroglu P. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 145 December (1-2) (2003) 127-134
16. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
17. Headache Classification subcommittee of the international headache society. The international classification of headache disorders, second edition. Cephalgia 24 Suppl. 1 (2004) 1-160
18. Heyser C.J., Masliah E., Samimi A., Campbell I.L., and Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94 February (4) (1997) 1500-1505
19. Borhani Haghighi A., Aflaki E., and Ketabchi L. The prevalence and characteristics of different types of headache in patients with Behçet's disease. Headache 48 March (3) (2008) 424-429
20. Saip S., Siva A., Altintas A., Kiyat A., Seyahi E., Hamuryudan V., et al. Headache in Behçet's syndrome. Headache 45 (2005) 911-919
21. Nishimoto N., Hashimoto J., Miyasaka N., Yamamoto K., Kawai S., Takeuchi T., et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X-ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 66 September (9) (2007) 1162-1167
22. Woo P., Wilkinson N., Prieur A.M., Southwood T., Leone V., Livermore P., et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7 6 (2005) R1281-1288
23. Borhani Haghighi A., and Safari A. Tocilizumab may be a potential addition to our weapons against neuro-Behcet's disease. Med Hypotheses 71 1 (2008) 156-157